Hydralazine injection how supplied storage and handling: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Hydralazine}} {{CMG}}; {{AE}} {{AK}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIU...") |
No edit summary |
||
| Line 4: | Line 4: | ||
==HOW SUPPLIED== | |||
[[image:hydra8.png]] | |||
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. | |||
This container closure is not made with natural rubber latex. | |||
N+ and NOVAPLUS are registered trademarks of Novation, LLC. | |||
Manufactured by: | |||
Fresenius Kabi USA, LLC | |||
Lake Zurich, IL 60047 | |||
451104B | |||
Revised: June 2013<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIUS KABI USA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3797028-c625-4f70-ae69-8a5f6f23f1b8 | publisher = | date = | accessdate = 10 March 2014 }}</ref> | |||
==References== | ==References== | ||
Revision as of 06:29, 11 March 2014
| Hydralazine |
|---|
| HYDRALAZINE tablet® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| HYDRALAZINE injection® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Hydralazine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
HOW SUPPLIED
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
This container closure is not made with natural rubber latex.
N+ and NOVAPLUS are registered trademarks of Novation, LLC.
Manufactured by:
Fresenius Kabi USA, LLC
Lake Zurich, IL 60047
451104B
Revised: June 2013[1]
References
- ↑ "HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIUS KABI USA, LLC]". Retrieved 10 March 2014.